Get the Daily Brief
Latest Biotech News
Real-Time Biomanufacturing Monitoring Partnership
Repligen and Univercells Technologies have partnered to integrate Repligen’s MAVEN® Real Time Glucose Control Platform with Univercells’ scale-X bioreactors. This collaboration enables real-time...
Advances in Fecal Microbiota Transplantation Research
Fecal microbiota transplantation (FMT), initially established for treating recurrent Clostridioides difficile infections, is gaining attention for broader therapeutic applications. Since 2017,...
FDA Regulatory Actions on Capricor Therapeutics’ Cell Therapy
The FDA has issued a complete response letter to Capricor Therapeutics, requesting additional efficacy data for Deramiocel, its off-the-shelf cell therapy targeting cardiac complications of...
Biopharma Workforce Challenges and Talent Crunch
Jason Beckwith, PhD, highlights an imminent 'talent singularity' in biomanufacturing expected by 2028, where demand for skilled professionals will outpace supply. The industry faces shortages due...
FDA Approval Trends and Regulatory Initiatives in 2025
The FDA approved three new molecular entities (NMEs) in June 2025, contributing to a total of 19 approvals so far this year, signaling continued drug pipeline activity. Concurrently, Commissioner...
Biopharma Funding Dynamics Mid-2025
Biopharma financing has shown notable activity in 2025, encompassing public and private rounds. Early-year data revealed cumulative capital deployment across multiple funding categories,...
Venture Capital Surge in Radiopharmaceutical Development
Radiopharma developers Actithera and Nuclidium secured venture capital investment as part of a broader funding wave encompassing Varda and Renasant, alongside public offerings from Rhythm, Cogent,...
Emerging AI Technologies and Genomics Testing Funding
Juniper Genomics announced a C$4.6 million seed funding round to expand its commercial and research operations focused on genomics testing for in vitro fertilization (IVF). Concurrently, Elon Musk...
Healthcare Policy and Access Innovations
Legislation introduced seeks to extend Medicare’s hospital-at-home reimbursement waiver through 2030, reinforcing the model’s role in reducing mortality and costs by enabling acute care in...
Proteomic Study Exposes New Protein Targets in Alzheimer’s
Researchers at Johns Hopkins University have used limited proteolysis mass spectrometry (LiP-MS) to uncover over 200 misfolded proteins potentially linked to age-related cognitive decline in a rat...
FDA Rejects Capricor’s Duchenne Cell Therapy Amid Data Gaps
Capricor Therapeutics received a complete response letter (CRL) from the FDA rejecting its biologics license application for deramiocel, an off-the-shelf cell therapy targeting cardiomyopathy in...
Merck’s $10B Bet Hinges on Lung Drug Patents in Verona Acquisition
Merck’s acquisition of Verona Pharma for $10 billion centers on Verona’s COPD drug, Ohtuvayre, whose main patent expired in 2020. For Merck to capitalize on the deal, secondary patents protecting...
Real-Time Monitoring Partnership Advances Viral Vector Manufacturing
Repligen Technologies and Univercells have partnered to integrate Repligen’s MAVEN® Real Time Glucose Control Platform into Univercells’ scale-X bioreactors to enable continuous monitoring of...
Biopharma Deal Volume Surges to $35 Billion in June 2025
Biopharma dealmaking skyrocketed in June 2025, reaching $35.07 billion, marking the highest monthly total of the year and contributing to a first-half 2025 deal value of $138.31 billion. This...
US Biotech Growth Lags While China Accelerates in 2025
Analysis shows that the U.S. biotech sector is yet to achieve significant growth momentum compared to China’s surging industry performance in 2025. Public market previews and reports from...
FDA Approvals Maintain Pace with Three New Molecular Entities in June
The FDA approved three new molecular entities (NMEs) in June 2025, contributing to a year-to-date total of 19 approvals with additional approvals already recorded in July. This steady regulatory...
Biomanufacturing Faces Talent Shortages by 2028, Experts Warn
Industry experts predict a biomanufacturing talent shortage by 2028 due to gaps in existing skills and increased technology demands. Jason Beckwith, PhD, emphasizes the need for cross-industry...
Emerging AI Tools Accelerate Vaccine and Antibody Research
Scripps Research scientists developed a microchip that rapidly maps antibody-virus interactions using minimal blood samples. This innovation provides faster and clearer insights into immune...
Chugai and Gero Collaborate on AI-Driven Age-Related Disease Targets
Chugai Pharmaceutical, a Roche subsidiary, has partnered with Singapore-based AI company Gero to identify drug targets for age-related diseases using Gero’s human data-centric platform. The...
Proteomic Advances Redefine Alzheimer’s Protein Misfolding Scope
Johns Hopkins University researchers have expanded the understanding of protein misfolding in age-related cognitive decline beyond amyloid-beta and tau. Using limited proteolysis mass spectrometry...